Endometrial cancer staging: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
Line 17: | Line 17: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor confined to the corpus uteri | | style="padding: 5px 5px; background: #F5F5F5;" | Tumor confined to the corpus uteri | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''IA''' | | style="padding: 5px 5px; background: #DCDCDC;" align="center" +| '''IA''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | No or less than half myometrial invasion | | style="padding: 5px 5px; background: #F5F5F5;" | No or less than half myometrial invasion | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''IB''' | | style="padding: 5px 5px; background: #DCDCDC;" align="center" +| '''IB''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Invasion equal to or more than half of the [[myometrium]] | | style="padding: 5px 5px; background: #F5F5F5;" | Invasion equal to or more than half of the [[myometrium]] | ||
|- | |- | ||
Line 29: | Line 29: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Local and/or regional spread of the tumor | | style="padding: 5px 5px; background: #F5F5F5;" | Local and/or regional spread of the tumor | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" |'''IIIA''' | |style="padding: 5px 5px; background: #DCDCDC;" align="center" +|'''IIIA''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades the serosa of the corpus uteri and/or adnexae | | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades the serosa of the corpus uteri and/or adnexae | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''IIIB''' | | style="padding: 5px 5px; background: #DCDCDC;" align="center" +|'''IIIB''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Vaginal involvement and/or parametrial involvement | | style="padding: 5px 5px; background: #F5F5F5;" | Vaginal involvement and/or parametrial involvement | ||
|- | |- | ||
| rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" | '''III C''' | | rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" align="center" +| '''III C''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Metastases to pelvic and/or para-aortic lymph nodes | | style="padding: 5px 5px; background: #F5F5F5;" | Metastases to pelvic and/or para-aortic lymph nodes | ||
|- | |- | ||
Line 45: | Line 45: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades bladder and/or bowel mucosa, and/or distant metastases | | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades bladder and/or bowel mucosa, and/or distant metastases | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''IVA''' | | style="padding: 5px 5px; background: #DCDCDC;" align="center" +| '''IVA''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invasion of [[bladder]] and/or bowel mucosa | | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invasion of [[bladder]] and/or bowel mucosa | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''IVB''' | | style="padding: 5px 5px; background: #DCDCDC;" align="center" +| '''IVB''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis, including intra-abdominal [[metastases]] and/or inguinal nodes | | style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis, including intra-abdominal [[metastases]] and/or inguinal nodes | ||
|- | |- |
Latest revision as of 14:12, 29 November 2018
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer staging On the Web |
American Roentgen Ray Society Images of Endometrial cancer staging |
Risk calculators and risk factors for Endometrial cancer staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
According to the FIGO cancer staging system, there are 4 stages of endometrial cancer.
Staging
Endometrial carcinoma is surgically staged using the FIGO cancer staging system.[1]
Stage | Findings |
---|---|
Stage I | Tumor confined to the corpus uteri |
IA | No or less than half myometrial invasion |
IB | Invasion equal to or more than half of the myometrium |
Stage II | Tumor invades cervical stroma but does not extend beyond the uterus |
Stage III | Local and/or regional spread of the tumor |
IIIA | Tumor invades the serosa of the corpus uteri and/or adnexae |
IIIB | Vaginal involvement and/or parametrial involvement |
III C | Metastases to pelvic and/or para-aortic lymph nodes |
(i) Positive pelvic nodes | |
(ii) Positive para-aortic nodes with or without positive pelvic lymph nodes | |
Stage IV | Tumor invades bladder and/or bowel mucosa, and/or distant metastases |
IVA | Tumor invasion of bladder and/or bowel mucosa |
IVB | Distant metastasis, including intra-abdominal metastases and/or inguinal nodes |